Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice. 21628403 2011
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 GeneticVariation disease BEFREE Recurrent genetic abnormalities in B-lymphoblastic leukemia with prognostic significance are well known and specifically delineated in the WHO 2008 classification (eg hyperdiploidy, t(9;22)(q34;q11.2); BCR-ABL1, t(12;21)(p13;q22); ETV6-RUNX1). 21822204 2011
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE These data indicate subclonal diversity at diagnosis, providing a variable basis for intraclonal origins of relapse and extended periods (years) of dormancy, possibly by quiescence, for stem cells in ETV6-RUNX1(+) acute lymphoblastic leukemia. 21482711 2011
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE Cytogenetics of long-term survivors of ETV6-RUNX1 fusion positive acute lymphoblastic leukemia. 19998443 2010
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE The ETV6-ARNT fusion is associated not only with AML but also with T-ALL. 20804916 2010
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE B lymphoblastic leukemia with ETV6 amplification. 21156245 2010
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease LHGDN ETV6/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia. 19100516 2009
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes. 19594616 2009
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease LHGDN TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan. 18635414 2008
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease LHGDN Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. 18445843 2008
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 GeneticVariation disease LHGDN The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1. 18767146 2008
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 GeneticVariation disease LHGDN Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia. 17972957 2008
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 GeneticVariation disease LHGDN Cytogenetic patterns in ETV6/RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia: A Nordic series of 245 cases and review of the literature. 17285576 2007
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE In intracellular NOTCH1 (ICN1)- and TEL-JAK2-induced T-cell lymphoblastic leukemia, two mouse models relevant to human malignancies, in vivo inhibition of calcineurin activity by CsA or FK506 induced apoptosis of leukemic cells and rapid tumor clearance, and substantially prolonged mouse survival. 17515895 2007
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease CTD_human Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. 17255265 2007
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 GeneticVariation disease LHGDN Presenting features of 201 children with acute lymphoblastic leukemia: comparison according to presence or absence of ETV6/RUNX1 rearrangement. 17854676 2007
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease LHGDN Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation. 17673463 2007
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization. 17374122 2007
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease LHGDN Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China. 17889709 2007
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China. 17889709 2007
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease LHGDN A novel TEL-AML1 fusion transcript involving the pro-apoptotic gene BCL-G in pediatric precursor B acute lymphoblastic leukemia. 16673018 2006
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE Near-tetraploidy in childhood B-cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1-positive leukemic cases. 16552772 2006
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 AlteredExpression disease LHGDN The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression. 16386788 2006
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 Biomarker disease BEFREE Variations of the immunogenotype and TEL deletions in children with TEL-AML1+ acute lymphoblastic leukemia support the hypothesis that relapses derive from a persistent TEL-AML1+ preleukemic/leukemic clone rather than a resistant leukemia. 16278392 2005
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400 GeneticVariation disease LHGDN Immunoglobulin and T-cell receptor gene rearrangements were analyzed in 41 children with a TEL-AML1+ acute lymphoblastic leukemia and an early (up to 30 months after diagnosis; n = 12) or late (at 30 months or later; n = 29) disease recurrence by a standardized PCR approach. 16278392 2005